Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and government authorities and academic institutions, as well as clinical, forensic, and academic laboratories. It operates in 70 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

Biotage AB (publ)

Biotage provides solutions for drug discovery and development, analytics, and environmental testing.

msh id	COM:BIOTAGE
symbol	BIOT
name	Biotage AB (publ)
homepage url	https://www.biotage.com
country	SE
sector	Healthcare
industry	Medical - Instruments & Supplies
market	STOCKS
employee count	669
crunchbase url	-
linkedin url	-
founders	-

market cap	1.24B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.21
growth cost of revenue	0.15
growth depreciation and amortization	0.57
growth ebitda	0.11
growth ebitda ratio	-0.06
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-1
growth gross profit	0.21
growth gross profit ratio	0.02

BIOT

COM:BIOTAGE

Biotage

Last Close

151.10

22/11 11:37

Market Cap

13.17B

Beta: -

Volume Today

4.87K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	142.13M
cost of revenue	142.13M
depreciation and amortization	13.74M
ebitda	43.35M
ebitda ratio	0.25
eps	0.31
eps diluted	0.31
operating expenses	76.37M
operating income	29.61M
operating income ratio	0.17

accounts receivables	-8.95M
capital expenditure	-8.39M
cash at beginning of period	40.67M
cash at end of period	54.79M
inventory	40.31M
working capital ttm	651M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-